FVB-Tg(Ckm-IGF1R*K1003R)1Dlr/J

Home
Services
R&D Services for Diabetes Mellitus and Diabetic Complications
Type 2 Diabetes Mellitus Research and Development Services
T2DM Modeling Service
T2DM Mouse Models
FVB-Tg(Ckm-IGF1R*K1003R)1Dlr/J

Inquiry

ace

* First Name
* Last Name
* Business Email
Phone
Company/Institution
Job Title
* Services or Products of Interest (DMM-001259) FVB-Tg(Ckm-IGF1R*K1003R)1Dlr/J
When do you expect your project to start?
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.

FVB-Tg(Ckm-IGF1R*K1003R)1Dlr/J

Inquiry

Cat. No.: DMM-001259

Status	Age	Sex
Live Mouse Frozen Embryo	4 weeks 12 weeks Customized Age	Male Female

Model Overview
Model Description	MKR transgenic mice have the murine Ckm promoter directing expression of the human IGF-1R gene containing the K1003R mutation. These mice may be useful for studying insulin signaling and Type 2 Diabetes.
Strain Name	FVB-TG（Ckm-IGF1R*K1003R）1Dlr/J
Background Strain	FVB/N
SPF	Yes
Research Application	Diabetes

Target Information
Target Name	Tg(Ckm-IGF1R*K1003R)1Dlr
Synonyms	MCK-KR-hIGF-IR,MKR
Gene ID	-

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Related Models

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Copyright © Ace Therapeutics. All Rights Reserved.

Top